These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 36353638)
1. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Long M; Zhou Z; Wei X; Lin Q; Qiu M; Zhou Y; Chen P; Jiang Y; Wen Q; Liu Y; Li R; Zhou X; Yu H Front Immunol; 2022; 13():1023349. PubMed ID: 36353638 [TBL] [Abstract][Full Text] [Related]
2. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis. Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412 [TBL] [Abstract][Full Text] [Related]
3. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma. Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167 [TBL] [Abstract][Full Text] [Related]
4. A New Inflammation-Related Risk Model for Predicting Hepatocellular Carcinoma Prognosis. Xing M; Li J Biomed Res Int; 2022; 2022():5396128. PubMed ID: 35572724 [TBL] [Abstract][Full Text] [Related]
5. A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma. Yan Q; Zheng W; Wang B; Ye B; Luo H; Yang X; Zhang P; Wang X BioData Min; 2021 May; 14(1):29. PubMed ID: 33962640 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of a robust immune-related risk signature for hepatocellular carcinoma. Liu Z; Jiao D; Liu L; Zhou X; Yao Y; Li Z; Li J; Chen J; Lei Q; Han X Medicine (Baltimore); 2021 Mar; 100(10):e24683. PubMed ID: 33725827 [TBL] [Abstract][Full Text] [Related]
7. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients. Ye D; Liu Y; Li G; Sun B; Peng J; Xu Q Front Oncol; 2021; 11():766072. PubMed ID: 34868990 [TBL] [Abstract][Full Text] [Related]
8. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells. Wang Y; Yang Y; Zhao Z; Sun H; Luo D; Huttad L; Zhang B; Han B BMC Cancer; 2022 Apr; 22(1):379. PubMed ID: 35397536 [TBL] [Abstract][Full Text] [Related]
9. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867 [No Abstract] [Full Text] [Related]
10. A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma. Zhang G; Su L; Lv X; Yang Q Cancer Cell Int; 2021 Oct; 21(1):522. PubMed ID: 34627241 [TBL] [Abstract][Full Text] [Related]
11. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma. Dai K; Liu C; Guan G; Cai J; Wu L BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781 [TBL] [Abstract][Full Text] [Related]
12. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma. Gao S; Zhang L; Wang H Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177 [TBL] [Abstract][Full Text] [Related]
14. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma. Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677 [TBL] [Abstract][Full Text] [Related]
15. Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients. Wang S; Cheng L; Jing F; Li G BMC Med Genomics; 2022 Aug; 15(1):177. PubMed ID: 35941638 [TBL] [Abstract][Full Text] [Related]
16. Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis. Lei J; Zhang D; Yao C; Ding S; Lu Z Cancer Control; 2020; 27(1):1073274820977114. PubMed ID: 33269615 [TBL] [Abstract][Full Text] [Related]
17. A novel epithelial-mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma. Shi Y; Wang J; Huang G; Zhu J; Jian H; Xia G; Wei Q; Li Y; Yu H Hepatol Int; 2022 Aug; 16(4):906-917. PubMed ID: 35699863 [TBL] [Abstract][Full Text] [Related]
18. Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment. Wei S; Tan J; Huang X; Zhuang K; Qiu W; Chen M; Ye X; Wu M J Transl Med; 2024 Jul; 22(1):711. PubMed ID: 39085893 [TBL] [Abstract][Full Text] [Related]
19. A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma. Li Q; Fan B; Ding J; Xiang X; Zhang J Medicine (Baltimore); 2021 Aug; 100(33):e26948. PubMed ID: 34414957 [TBL] [Abstract][Full Text] [Related]
20. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma. Liu T; Wu H; Qi J; Qin C; Zhu Q Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]